Pak No. 5
Natural health product licensed in Canada
- Other names
- Tablet No. 5 Lg Oval Dark Red, Universal Nutrition Animal Pak Tablet No. 5
- Licence holder
- Universal Nutrition
- NPN or DIN-HM
- 80088655
- Status
- Active licence
- Licence date
- 11 October 2018
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 31 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phosphore Source : Phosphate de calcium, dibasique, dihydraté | 112.24 mg | 112,240 µg |
| Inuline Source : Inuline | 62.5 mg | Not calculated |
| Calcium Source : Phosphate de calcium, dibasique, dihydraté | 146.2 mg | 146,200 µg |
| Pinus pinaster Source : Écorce et bourgeons Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 mg | 100 mg | Not calculated |
| Choline Source : Bitartrate de choline | 125 mg | Not calculated |
| Chrome Source : Chlorure de chrome (III) | 0.031 mg | 31 µg |
Non-medicinal ingredients
Dioxyde de silicium, Eau, Cellulose microcristalline, Stéarate de magnésium, Acide stéarique, Glaçure pharmaceutique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Workout supplement Athletic support Source of protein which helps build and repair body tissues Source of amino acids involved in muscle protein synthesis Assists in the building of lean muscle mass when combined with regular resistance training and a healthy balanced diet Helps to support liver function Provides support for healthy glucose metabolism Helps the body to metabolize carbohydrates and fats
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding If you are taking medications which inhibit peristaltic movement, consult a health care practitioner prior to use (e.g. opioids, loperamide) If you have symptoms such as abdominal pain, nausea, vomiting or fever, consult a health care practitioner prior to use If you are experiencing a sudden change in bowel habits that has persisted for more than 2 weeks, undiagnosed rectal bleeding, or have failed to defecate following the use of a laxative product, consult a health care practitioner prior to use Consult a health care practitioner prior to use if you have a liver disease, a kidney disease, a seizure disorder or if you are following a low protein diet Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners or if your cardiovascular condition worsens If you have a gastrointestinal lesion/ ulcer, are taking an anticoagulant/ blood thinner, anti-inflammatory or antibiotic, or are having surgery, consult a health care practitioner prior to use
- Contre-indications
Do not use if you have had a heart attack/myocardial infarction If you have a milk allergy, do not use this product
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use Nausea, vomiting, and diarrhoea have been known to occur, in which case discontinue use (and consult a health care practitioner) Some people may experience gastrointestinal discomfort (such as diarrhea)
Source
Official Health Canada record, licence 80088655
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.